Pharma-Bio Modular Facilities, Prefab Equipment Gain Traction
Pharma-Bio Modular Facilities, Prefab Equipment Gain Traction
April 26, 2022--Researched by Industrial Info Resources (Sugar Land, Texas)--Conventional pharmaceutical and biotech manufacturing facilities are very capital intensive and have prolonged construction timelines. These brick-and-mortar facilities contain built-in operating equipment anchored into the facility's substructure, requiring major renovation costs and construction timelines.
Modular facilities also predominately involve brick-and-mortar construction, with all major utilities embedded in the building's infrastructure. However, operating equipment is prefabricated offsite, with skid-mounted platforms subsequently integrated into the facility. The skid-mounted platforms enable reconfiguration and equipment updates without the costs and time constraints of major renovations required by conventional facilities.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
- Turner Construction Involved in More than $24 Billion Worth of U.S. Project...
- Medical Devices & Equipment Sector Brings Billions in Spending to the U.S.